About Biostar Pharmaceuticals (NASDAQ:BSPM)
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BSPM
CUSIPN/A
Phone011-86-29-3368-6638
Debt
Debt-to-Equity RatioN/A
Current Ratio0.19%
Quick Ratio0.16%
Price-To-Earnings
Trailing P/E Ratio4.04
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$2.38 million
Price / Sales3.14
Cash FlowN/A
Price / CashN/A
Book Value$13.98 per share
Price / Book0.20
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-5,690,000.00
Net MarginsN/A
Return on Equity2.59%
Return on Assets2.25%
Miscellaneous
Employees200
Outstanding Shares2,640,000
Biostar Pharmaceuticals (NASDAQ:BSPM) Frequently Asked Questions
What is Biostar Pharmaceuticals' stock symbol?
Biostar Pharmaceuticals trades on the NASDAQ under the ticker symbol "BSPM."
How were Biostar Pharmaceuticals' earnings last quarter?
Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) announced its earnings results on Wednesday, November, 15th. The company reported ($0.50) earnings per share for the quarter. During the same quarter in the prior year, the business posted ($3.12) earnings per share. View Biostar Pharmaceuticals' Earnings History.
Who are some of Biostar Pharmaceuticals' key competitors?
Some companies that are related to Biostar Pharmaceuticals include OHR Pharmaceutical (OHRP), Onconova Therapeutics (ONTX), RXi Pharmaceuticals (RXII), Acura Pharmaceuticals (ACUR), EpiCept (IMNP), Dare Bioscience (DARE), Auris Medical (EARS), EyeGate Pharma (EYEG), Anthera Pharmaceuticals (ANTH), Heat Biologics (HTBX), Bioblast Pharma (ORPN), Apricus Biosciences (APRI), Cotinga Pharmaceuticals (COTQF), Orexigen Therapeutics (OREX), Argos Therapeutics (ARGS), Rosetta Genomics (ROSG), Affymax (AFFY) and TetraLogic (TLOG).
Who are Biostar Pharmaceuticals' key executives?
Biostar Pharmaceuticals' management team includes the folowing people:
- Mr. Ronghua Wang, Chairman, CEO & Pres (Age 62)
- Mr. Zhenghong Wang, Chief Operating Officer (Age 38)
- Ms. Xiaojuan Zhai, Chief Financial Officer (Age 29)
- Prof. Xiaohui Zheng, Chief Scientist (Age 50)
- Ms. Shuang Gong, Director of Admin. & Sec. of Board (Age 51)
Has Biostar Pharmaceuticals been receiving favorable news coverage?
News coverage about BSPM stock has trended somewhat positive on Saturday, according to Accern. The research firm ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Biostar Pharmaceuticals earned a media sentiment score of 0.09 on Accern's scale. They also gave press coverage about the company an impact score of 44.46 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of Biostar Pharmaceuticals?
Shares of BSPM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Biostar Pharmaceuticals' stock price today?
One share of BSPM stock can currently be purchased for approximately $2.83.
How big of a company is Biostar Pharmaceuticals?
Biostar Pharmaceuticals has a market capitalization of $7.46 million and generates $2.38 million in revenue each year. Biostar Pharmaceuticals employs 200 workers across the globe.
How can I contact Biostar Pharmaceuticals?
Biostar Pharmaceuticals' mailing address is NO. 588 SHIJI XI AVENUE, XIANYANG SHAANXI PROVINCE F4, 712046. The company can be reached via phone at 011-86-29-3368-6638.
MarketBeat Community Rating for Biostar Pharmaceuticals (BSPM)
MarketBeat's community ratings are surveys of what our community members think about Biostar Pharmaceuticals and other stocks. Vote "Outperform" if you believe BSPM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BSPM will underperform the S&P 500 over the long term. You may vote once every thirty days.
Biostar Pharmaceuticals (NASDAQ:BSPM) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/21/2016 forward)
Biostar Pharmaceuticals (NASDAQ:BSPM) Earnings History and Estimates Chart
Biostar Pharmaceuticals (NASDAQ BSPM) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/15/2017 | Q3 17 | | ($0.50) | | | View | N/A |  |
| 5/19/2017 | Q1 2017 | | ($0.38) | | | View | N/A | |
| 4/13/2017 | Q4 2016 | | $1.63 | | $0.32 million | View | N/A | |
| 11/21/2016 | Q3 16 | | ($0.71) | | $0.65 million | View | N/A | |
| 8/22/2016 | Q2 | | ($3.12) | | $0.62 million | View | N/A | |
| 5/23/2016 | Q1 | | ($0.28) | | $0.80 million | View | N/A | |
| 11/23/2015 | Q3 15 | | ($0.08) | | $4.21 million | View | N/A | |
| 8/19/2015 | Q215 | | ($0.03) | $19.20 million | $14.20 million | View | N/A | |
| 5/15/2015 | Q1 15 | | ($0.01) | | $6.91 million | View | N/A | |
| 4/15/2015 | Q4 2014 | | $1.26 | | $14.39 million | View | N/A | |
| 11/14/2014 | Q3 2014 | | $0.14 | | $14.65 million | View | N/A | |
| 8/14/2014 | Q2 2014 | | $0.77 | | $19.20 million | View | N/A | |
| 5/15/2014 | Q1 2014 | | $0.14 | | $13.18 million | View | N/A | |
| 3/31/2014 | Q4 2013 | | $0.28 | | $10.98 million | View | N/A | |
| 11/14/2013 | Q3 2013 | | $0.21 | | $15.01 million | View | N/A | |
| 8/19/2013 | Q2 2013 | | ($0.06) | $8.20 million | $14.70 million | View | N/A | |
| 5/16/2013 | Q1 2013 | | $0.42 | | $12.09 million | View | N/A | |
| 4/15/2013 | Q4 2012 | | ($4.76) | | | View | N/A | |
| 11/19/2012 | Q312 | | ($0.63) | $24.78 million | $9.97 million | View | N/A | |
| 8/14/2012 | Q2 2012 | | ($2.66) | | | View | N/A | |
| 5/15/2012 | Q1 2012 | | $2.20 | | | View | N/A | |
| 3/27/2012 | Q4 2011 | | $1.72 | | | View | N/A | |
| 11/14/2011 | Q3 2011 | | $3.32 | | | View | N/A | |
| 8/15/2011 | Q2 2011 | | $3.13 | | | View | N/A | |
| 5/16/2011 | Q1 2011 | $2.52 | $2.08 | | | View | N/A | |
| 3/25/2011 | Q4 2010 | $4.62 | $4.62 | | | View | N/A | |
| 11/15/2010 | Q3 2010 | | $2.62 | | | View | N/A | |
| 8/17/2010 | Q2 2010 | | $4.22 | | | View | N/A | |
| 5/17/2010 | Q1 2010 | | $1.74 | | | View | N/A | |
| 4/1/2010 | Q4 2009 | | ($0.92) | | | View | N/A | |
| 11/12/2009 | Q3 2009 | | $2.77 | | | View | N/A | |
| 8/14/2009 | Q2 2009 | | $3.57 | | | View | N/A | |
| 5/14/2009 | Q1 2009 | | $1.64 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Biostar Pharmaceuticals (NASDAQ:BSPM) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Biostar Pharmaceuticals (NASDAQ BSPM) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 17.20%
Institutional Ownership Percentage: 1.14%
Biostar Pharmaceuticals (NASDAQ BSPM) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Biostar Pharmaceuticals (NASDAQ BSPM) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Who Are The Major Shareholders Of Biostar Pharmaceuticals Inc (NASDAQ:BSPM)?
finance.yahoo.com - April 10 at 5:22 PM |
 | Biostar Pharmaceuticals (BSPM) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 4 at 1:12 AM |
| Is Biostar Pharmaceuticals Inc (NASDAQ:BSPM) A Financially Sound Company?
finance.yahoo.com - March 9 at 9:55 AM |
| Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification
finance.yahoo.com - February 8 at 7:01 AM |
| Biostar Pharma Post Huge Gains, Pipeline Review, and a New Product
finance.yahoo.com - February 1 at 3:28 PM |
| Why Biostar Pharmaceuticals Inc (NASDAQ:BSPM) May Not Be As Efficient As Its Industry
finance.yahoo.com - January 29 at 7:24 AM |
| December Undervalued Opportunities – Biostar Pharmaceuticals And More
finance.yahoo.com - December 29 at 10:24 AM |
 | Biostar Pharma (BSPM) Reports Compliance with NASDAQ Continued Listing Requirement
www.streetinsider.com - December 5 at 10:42 AM |
| Biostar Regains Compliance with NASDAQ Continued Listing Requirement
finance.yahoo.com - December 4 at 4:53 PM |
| Network-1 Technologies And Other Top Undervalued Stocks
finance.yahoo.com - November 24 at 11:24 AM |
 | Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017
www.prnewswire.com - November 20 at 4:23 PM |
| Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017
finance.yahoo.com - November 16 at 12:12 PM |
| Biostar Pharmaceuticals, Inc. (BSPM) Releases Earnings Results
www.americanbankingnews.com - November 16 at 10:14 AM |
| Is Biostar Pharmaceuticals Inc’s (BSPM) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - November 3 at 10:28 PM |
| 3 Trending Biotech Stocks To Watch On Monday
finance.yahoo.com - October 9 at 5:32 PM |
| Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
finance.yahoo.com - August 28 at 4:45 PM |
| Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice
finance.yahoo.com - August 28 at 4:45 PM |
| Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - August 14 at 1:46 AM |
 | EARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q1 Earnings Report
www.rttnews.com - May 21 at 11:26 AM |
| BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
biz.yahoo.com - February 24 at 9:13 PM |
| BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - February 9 at 9:18 PM |
 | Drug Makers Stocks on Investors' Radar -- Immune Pharma, Sanofi, Biostar Pharma, and Heron Therapeutics
www.bizjournals.com - January 3 at 10:00 AM |
| EARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q3 Earnings Report
www.rttnews.com - November 22 at 3:30 PM |
| Biostar Pharmaceuticals Inc. (BSPM) Is Spiking To The Upside
www.rttnews.com - October 18 at 3:56 PM |
| Biostar Pharma (BSPM) Enters 425k Share Securities Purchase Agreement
www.streetinsider.com - October 13 at 10:20 AM |
| Biostar Announces Execution of Agreement for $1.91 Million Registered Direct ...
www.prnewswire.com - October 12 at 4:13 PM |
| Biostar Pharma (BSPM) Announces Launch of 'Easy Breathing' Product; Will Target Rhinitis, Sinusitis
www.streetinsider.com - October 12 at 8:27 AM |
| Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis
www.prnewswire.com - October 12 at 8:27 AM |
 | It was a bad day for stocks, but these three delivered good news
investorplace.com - October 12 at 8:27 AM |
| Biostar Pharmaceuticals Inc. (BSPM) Surged After New Product Announcement
www.rttnews.com - October 12 at 8:27 AM |
 | Biostar Pharma Skyrockets on New Chinese Product Launch
247wallst.com - October 11 at 3:46 PM |
| BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
biz.yahoo.com - September 23 at 9:05 AM |
| Biostar Pharma (BSPM) Signs LOI to Acquire Xianyang Yongsheng Health Products
www.streetinsider.com - September 22 at 4:07 PM |
| Biostar Pharmaceuticals Inc. (BSPM) Is Up Sharply In Early Trade
www.rttnews.com - September 21 at 8:31 AM |
 | Mid-Morning Market Update: Markets Open Higher; Best Buy Beats Q2 Expectations
www.benzinga.com - August 23 at 4:03 PM |
| EARNINGS SUMMARY: Details of Biostar Pharmaceuticals Inc. Q2 Earnings Report
www.rttnews.com - August 23 at 4:02 PM |
| BIOSTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - June 13 at 5:02 PM |
| Biostar Pharmaceuticals Inc. (BSPM) Has Jumped To Nearly A 2-Month High
www.rttnews.com - June 8 at 4:29 PM |
Biostar Pharmaceuticals (NASDAQ:BSPM) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Biostar Pharmaceuticals (NASDAQ:BSPM) Income Statement, Balance Sheet and Cash Flow Statement
Biostar Pharmaceuticals (NASDAQ BSPM) Stock Chart for Saturday, April, 21, 2018
Loading chart…
